No abstract available
MeSH terms
-
Adenocarcinoma / drug therapy
-
Adenocarcinoma / metabolism
-
Adenocarcinoma / mortality
-
Adenocarcinoma / pathology*
-
Albumins / administration & dosage
-
Albumins / pharmacology*
-
Animals
-
Antineoplastic Agents / pharmacology*
-
Antineoplastic Agents / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Clinical Trials as Topic
-
Deoxycytidine / administration & dosage
-
Deoxycytidine / analogs & derivatives
-
Disease-Free Survival
-
Erlotinib Hydrochloride
-
Gemcitabine
-
Hedgehog Proteins / drug effects
-
Hedgehog Proteins / metabolism*
-
Humans
-
Off-Label Use
-
Osteonectin / metabolism
-
Paclitaxel / administration & dosage
-
Paclitaxel / pharmacology*
-
Pancreatic Neoplasms / drug therapy
-
Pancreatic Neoplasms / metabolism
-
Pancreatic Neoplasms / mortality
-
Pancreatic Neoplasms / pathology*
-
Quinazolines / administration & dosage
-
Signal Transduction / drug effects
-
Survival Analysis
-
United States / epidemiology
Substances
-
130-nm albumin-bound paclitaxel
-
Albumins
-
Antineoplastic Agents
-
Hedgehog Proteins
-
Osteonectin
-
Quinazolines
-
Deoxycytidine
-
Erlotinib Hydrochloride
-
Paclitaxel
-
Gemcitabine